Profiling of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small cell lung cancer.
about
The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.Pachymic acid induces apoptosis via activating ROS-dependent JNK and ER stress pathways in lung cancer cells.Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma.Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patientsAberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients.The marine-derived pachycladin diterpenoids as novel inhibitors of wild-type and mutant EGFR.Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer.Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium.MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression.Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients.Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.
P2860
Q35095549-0079304E-0A48-4FFD-87B4-2301CC752490Q35552019-B983B655-6EC8-4C46-9E03-76D0434CE7B6Q35914434-ED8D557C-7BA6-4A80-B80A-391DB212D954Q35919703-CF8F9DBD-8A2B-4874-A671-782CC47E20EEQ36879739-00FF41F7-662D-4E6C-98A7-83EE5BD3E9DCQ37667783-47F11CA4-9B8B-4747-A210-C7AB03D51A55Q38726762-82A0C2D6-4BF3-4019-91A4-45FFA41BF9BBQ38887635-B139A629-AB4F-497A-9788-C961A285CBC9Q40873556-C24C74F4-117C-4273-8A4F-A1A06C2F293BQ42395477-42E0B76F-8C4C-42D8-8DDA-08E0371F348DQ45833730-69416C99-345E-4E10-8750-58B4CBE9D5BAQ49720695-7E92C5FC-6903-41C8-9E92-CDF16AB53F85Q52764639-AC6A2CF5-075C-4908-B768-472EE58A4517
P2860
Profiling of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Profiling of phospho-AKT, phos ...... in non-small cell lung cancer.
@en
Profiling of phospho-AKT, phos ...... in non-small cell lung cancer.
@nl
type
label
Profiling of phospho-AKT, phos ...... in non-small cell lung cancer.
@en
Profiling of phospho-AKT, phos ...... in non-small cell lung cancer.
@nl
prefLabel
Profiling of phospho-AKT, phos ...... in non-small cell lung cancer.
@en
Profiling of phospho-AKT, phos ...... in non-small cell lung cancer.
@nl
P2093
P2860
P50
P356
P1476
Profiling of phospho-AKT, phos ...... in non-small cell lung cancer
@en
P2093
Catherine Conway
Haruhisa Kitano
Jun Hanaoka
Kris Ylaya
Mikiko Takikita
Yoshinori Doki
P2860
P304
P356
10.1369/0022155414523022
P577
2014-01-31T00:00:00Z